Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from InMode ( (INMD) ).
On November 5, 2025, InMode Ltd. announced its financial results for the third quarter of 2025, reporting revenues of $93.2 million, a decrease from $130.2 million in the same period of 2024. The company experienced a decline in gross margins and net income compared to the previous year, attributed to lower sales in the U.S., its most profitable region. Despite the challenging economic conditions and cautious consumer sentiment, InMode remains committed to strategic investments and regional growth, highlighted by the appointment of Michael Dennison as the new President of North America. The company is also involved in ongoing legal proceedings related to a shareholder class action, with the court dismissing most of the claims but allowing for a replead.
The most recent analyst rating on (INMD) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on InMode stock, see the INMD Stock Forecast page.
Spark’s Take on INMD Stock
According to Spark, TipRanks’ AI Analyst, INMD is a Outperform.
InMode’s strong financial performance and undervaluation are key strengths, but technical indicators and reduced guidance present challenges. The company’s strategic expansions and strong gross margins are positive, but market challenges and increased expenses weigh on the outlook.
To see Spark’s full report on INMD stock, click here.
More about InMode
InMode Ltd. is a leading global provider of innovative medical technologies, specializing in the development and commercialization of minimally invasive aesthetic solutions. The company focuses on delivering advanced medical devices that cater to the needs of the aesthetic industry, enhancing patient outcomes and offering effective solutions for practitioners.
Average Trading Volume: 848,234
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.02B
See more data about INMD stock on TipRanks’ Stock Analysis page.